Feb 5 (Reuters) - Hims & Hers Health Inc HIMS.N:
HIMS & HERS EXPANDS PERSONALIZED WEIGHT LOSS PORTFOLIO WITH ACCESS TO COMPOUNDED SEMAGLUTIDE PILLS STARTING AT $49/MONTH*
HIMS & HERS HEALTH INC: THIS COMPOUNDED PRODUCT USES A DIFFERENT FORMULATION AND DELIVERY SYSTEM THAN FDA-APPROVED ORAL SEMAGLUTIDE
Source text: ID:nBw4YMZjNa
Further company coverage: HIMS.N
((Reuters.Briefs@thomsonreuters.com;))